articleThe Journal of Experimental MedicineFeb 1, 2010BRONZE OA

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

Délégation Paris 5 · Inserm · +23 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Most patients with autoimmune polyendocrine syndrome type I (APS-I) display chronic mucocutaneous candidiasis (CMC). We hypothesized that this CMC might result from autoimmunity to interleukin (IL)-17 cytokines. We found high titers of autoantibodies (auto-Abs) against IL-17A, IL-17F, and/or IL-22 in the sera of all 33 patients tested, as detected by multiplex particle-based flow cytometry. The auto-Abs against IL-17A, IL-17F, and IL-22 were specific in the five patients tested, as shown by Western blotting. The auto-Abs against IL-17A were neutralizing in the only patient tested, as shown by bioassays of IL-17A activity. None of the 37 healthy controls and none of the 103 patients with other autoimmune…

Citation impact

720
total citations
FWCI
37.14
Percentile
100%
References
41
Citations per year

Authors

29

Topics & keywords

Keywords
  • Chronic mucocutaneous candidiasis
  • Autoantibody
  • Immunology
  • Autoimmunity
  • Medicine
  • Interleukin 17
  • B-cell activating factor
  • Interleukin
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.